전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
v rámci registrační studie porovnávající firmagon s leuprorelinem byly periodicky pořizovány elektrokardiogramy.
in the confirmatory study comparing firmagon to leuprorelin periodic electrocardiograms were performed.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
klinický přínos pro degarelix ve srovnání s leuprorelinem plus antiandrogenem v počáteční fázi léčby nebyl zjištěn.
the clinical benefit for degarelix compared to leuprorelin plus anti-androgen in the initial phase of treatment has not been demonstrated.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
18 primární end- point studie bylo potlačení hladiny testosteronu po jednoroční léčbě degarelixem nebo leuprorelinem.
the primary end-point in the study was testosterone suppression rates after one year of treatment with degarelix or leuprorelin.
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질:
v jedné hlavní studii byly u 610 mužů s karcinomem prostaty ve všech stádiích onemocnění srovnávány dvě dávky přípravku firmagon s leuprorelinem.
two doses of firmagon have been compared with leuprorelin in one main study involving 610 men with prostate cancer at all stages of the disease.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
zmenšení velikosti myomů bylo obecně u pacientek původně léčených ulipristal-acetátem během období sledování zachováno, ale došlo k určitému opakovanému růstu u pacientek léčených leuprorelinem.
myoma size reduction was generally maintained during this follow-up period in patients originally treated with ulipristal acetate but some re-growth occurred in patients treated with leuprorelin.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
tři (< 1%) z 409 pacientů léčených degarelixem a čtyři (2%) z 201 pacientů léčených leuprorelinem 7, 5 mg mělo qtcf ≥ 500 ms.
three (< 1%) out of 409 patients in the degarelix group and four (2%) out of 201 patients in the leuprorelin 7.5 mg group, had a qtcf ≥ 500 msec.
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
경고: 보이지 않는 HTML 형식이 포함되어 있습니다
leuprorelin
leuprolide
마지막 업데이트: 2014-12-09
사용 빈도: 24
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.